Nicotine delivery, tolerability and reduction of smoking urge in smokers following short-term use of one brand of electronic cigarettes Health behavior, health promotion and society

BMC Public Health

Volumn 15, Issue 1, 2015, Pages

  D'Ruiz, Carl D ^a   Graff, Donald W ^b   Yan, X Sherwin ^c  

^a ITG Brands LLC AW Spears Research Center RandD Department of Scientific Affairs   (United States)

^b CELERION   (United States)

^c LORILLARD TOBACCO COMPANY   (United States)

Author keywords

Adverse events; Clinical trial; Crossover study; Electronic cigarettes; Pharmacodynamics; Pharmacokinetics; Plasma nicotine; Smoking urge; Tolerability

Indexed keywords

MENTHOL; NICOTINE;

ADULT; ADVERSE EFFECTS; BLOOD; CHEMISTRY; COMPARATIVE STUDY; CONTROLLED STUDY; COUGH; CRAVING; CROSSOVER PROCEDURE; DIZZINESS; ELECTRONIC CIGARETTE; FEMALE; HEADACHE; HUMAN; MALE; MIDDLE AGED; PHARYNGITIS; PHYSIOLOGY; PREVENTION AND CONTROL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SMOKING; SMOKING CESSATION; TOBACCO; TOBACCO USE DISORDER;

ADULT; COUGH; CRAVING; CROSS-OVER STUDIES; DIZZINESS; ELECTRONIC CIGARETTES; FEMALE; HEADACHE; HUMANS; MALE; MENTHOL; MIDDLE AGED; NICOTINE; PHARYNGITIS; SINGLE-BLIND METHOD; SMOKING; SMOKING CESSATION; TOBACCO; TOBACCO PRODUCTS; TOBACCO USE DISORDER;

EID: 84942937249     PISSN: None     EISSN: 14712458     Source Type: Journal    
DOI: 10.1186/s12889-015-2349-2     Document Type: Article

References (26)

1. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (DHHS), National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health. The health consequences of smoking - 50 years of progress: a report of the surgeon general. 2014.
2. Caponnetto P, Campagna D, Cibella F, Morjaria JB, Caruso M, Russo C, et al. EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One. 2013;8(6):e66317. doi: 10.1371/journal.pone.0066317. Print 2013.
3. Etter JF, Bullen C. A longitudinal study of electronic cigarette users. Addict Behav. 2014;39:491-4.
4. Farsalinos KE, Polosa R. Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarette substitutes: a systematic review. Ther Adv Drug Saf. 2014;5(2):67-86.
5. Goniewicz ML, Knysak J, Gawron M, Kosmider L, Sobczak A, Kurek J, et al. Levels of selected carcinogens and toxicants in vapour from electronic cigarettes. Tob Control. 2014;23:133-9.
6. Polosa R, Caponnetto P, Morjaria JB, Papale G, Campagna D, Russo C. Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health. 2014;11:786.
7. Vansickel AR, Cobb CO, Weaver MF, Eissenberg T. A clinical laboratory model for evaluating the acute effects of electronic "cigarettes": nicotine delivery profile and cardiovascular and subjective effects. Cancer Epidemiol Biomarkers Prev. 2010;19:1945-53.
8. Bullen C, McRobbie H, Thornley S, Glover M, Lin R, Laugesen M. Effect of an electronic nicotine delivery device (e cigarette) on desire to smoke and withdrawal, user preferences and nicotine delivery: randomized cross-over trial. Tob Control. 2010;19:98-103.
9. Dawkins L, Corcoran O. Acute electronic cigarette use: nicotine delivery and subjective effects in regular users. Psychopharmacology. 2014;231(2):401-7.
10. Vansickel AR, Eissenberg T. Electronic cigarettes: effective nicotine delivery after acute administration. Nicotine Tob Res. 2013;15(1):267-70. doi: 10.1093/ntr/ntr316.
11. Nides MA, Leischow SJ, Bhatter M, Simmons M. Nicotine blood levels and short-term smoking reduction with an electronic nicotine delivery system. Am J Health Behav. 2014;38(2):265-74.
12. Etter JF. Electronic cigarettes: a survey of users. BMC Public Health. 2010;10:231. doi: 10.1186/1471-2458-10-231.
13. Polosa R, Morjaria JB, Caponnetto P, Campagna D, Russo C, Alamo A, et al. Effectiveness and tolerability of electronic cigarette in real-life: a 24-month prospective observational study. Intern Emerg Med. 2013. doi: 10.1007/s11739-013-0977-z. PubMed.
14. Caponnetto P, Campagna D, Papale G, Russo C, Polosa R. The emerging phenomenon of electronic cigarettes. Expert Rev Respir Med. 2012;6:63-74.
15. Callahan-Lyon P. Electronic cigarettes: human health effects. Tob Control. 2014;23 suppl 2:ii36-40.
16. Hajek P, Etter JF, Benowitz N, Eissenberg T, McRobbie H. Electronic cigarettes: review of use, content, safety, effects on smokers and potential for harm and benefit. Addiction. 2014. doi: 10.1111/add.12659.
17. Federal Trade Commission. 2006 and 2007 FTC Tar, Nicotine, and Carbon Monoxide Reports. 2012. Released under the Freedom of Information Act on May 15, 2012 and available at: http://www.econdataus.com/smoke.html. Accessed September 10, 2014.
18. Vansickel AR, Weaver MF, Eissenberg T. Clinical laboratory assessment of the abuse liability of an electronic cigarette. Addiction. 2012;107:1493-500.
19. Norton KJ, June KM, O'Connor RJ. Initial puffing behaviors and subjective responses differ between an electronic nicotine delivery system and traditional cigarettes. Tob Induc Dis. 2014;12:17.
20. Health Canada Method: Determination of "Tar", Nicotine and Carbon Monoxide in Mainstream Tobacco Smoke, 1999; http://edge.rit.edu/content/P10056/public/ Health%20Canada%20Nicotine (last accessed 2 April 2015).
21. Tayyarah R, Long GA. Comparison of select analytes in aerosol from e-cigarettes with smoke from conventional cigarettes and with ambient air. Reg Tox and Pharm. 2014;70(3):704-10.
22. Heatherton TF, Kozlowski LT, Frecker RC, Fagerström KO. The Fagerström test for nicotine dependence: a revision of the Fagerström tolerance questionnaire. Br J Addict. 1991;86(9):1119-27.
23. Fagerström K. Determinants of tobacco use and renaming the FTND to the Fagerstrom test for cigarette dependence. Nicotine Tob Res. 2012;14(1):75-8. doi: 10.1093/ntr/ntr137.
24. Yan XY, D'Ruiz CDD. Effects of using electronic cigarettes on nicotine delivery and cardiovascular function in comparison with regular cigarettes. Reg Tox and Pharm. 2015;71:24-34.
25. Benowitz NL. Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu Rev Pharmacol Toxicol. 2009;49:57-71.
26. Polosa R, Morjaria J, Caponnetto P, Caruso M, Strano S, Battaglia E, et al. Effect of smoking abstinence and reduction in asthmatic smokers switching to electronic cigarettes: evidence for harm reversal. Int J Environ Res Public Health. 2014;11:4965-77.